VIT — Vitura Health Income Statement
0.000.00%
Last trade - 00:00- AU$11.27m
- AU$21.70m
- AU$131.16m
Annual income statement for Vitura Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 67 | 117 | 124 | 124 | 131 |
| Cost of Revenue | |||||
| Gross Profit | 25.4 | 40.5 | 34.2 | 33.8 | 28.4 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 57.2 | 97.3 | 119 | 119 | 136 |
| Operating Profit | 9.74 | 20.1 | 4.56 | 4.71 | -5.29 |
| Net Income Before Taxes | 9.74 | 20.1 | 4.56 | 4.71 | -5.29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.01 | 13.8 | 3.25 | 3.06 | -4.41 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.05 | 13.8 | 3.51 | 3.32 | -4.39 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.05 | 13.8 | 3.51 | 3.32 | -4.39 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.012 | 0.024 | 0.006 | 0.005 | -0.005 |
| Dividends per Share |